Olympus will keep focusing on high end mirrorless despite challenges

The latest financial report from Olympus indicates that they intend to stay the course despite the challenging environment.

Olympus has just released their fiscal year 2018 results, and it appears their medical business led the way for the year, with increased sales bringing the overall consolidated revenue to ¥786,497 million (up 6.2% year on year). Operating profit was ¥81,029 (up 13.8% year on year) as the cost of restructuring the manufacturing location in the Imaging Business was offset by increased profits in the Medical Business and Scientific Solutions Business.

As you can see from the slides below, Olympus doesn’t expect to change strategy or numeric targets for the upcoming fiscal year, but will instead work on promoting structural reforms to ensure enduring profitability. What’s interesting to note is that they’re going to continue to focus on high-margin mirrorless cameras and interchangeable lenses like the flagship OM-D E-M1 Mark II.

They still expect an operating loss due to recording of expenses related to ceased operations of the Shenzhen manufacturing subsidiary in China, but otherwise they expect a third consecutive year of operating profit.

Sources: Olympus, Mirrorless Rumors

Our articles may contain affiliate links. If you buy through these links, we may earn a small commission.

Share this article